查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1424468

生物分解性支架市場：依產品類型、依材料類型、依最終用戶、按地區

Biodegradable Stents Market, By Product Type, By Material Type, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計2023年生物分解性支架的全球市場規模為3.889億美元，預計2023年至2030年年複合成長率為7.2%，2030年將達到6.347億美元。

報告範圍 報告詳情
基準年 2022年 2023/2024年市場規模 3.889 億美元
實際資料 2018-2021 預測期 2023-2030
預測期間2023/2024 至2030/2031年年複合成長率： 7.20% 2030/2031年預測值 6.347 億美元
圖 1.2023年依地區分類的生物分解性支架的全球市場佔有率（%）
可生物分解支架市場-IMG1

生物分解性支架市場在更廣泛的醫療設備產業中迅速發展。生物分解性支架也稱為生物可吸收支架，用於治療冠狀動脈疾病和周邊動脈疾病。這些支架目的是疏通阻塞的動脈，並在一段時間內逐漸溶解在體內，無需永久性金屬植入，並且與傳統支架相關的併發症風險也會降低。全球可生物分解性支架市場受到多種因素的推動，包括心血管疾病盛行率的上升、技術進步以及對微創手術的偏好。對市場產生影響的另一個因素是對更好、更安全的支架替代傳統支架的需求不斷成長，傳統支架可能導致血栓症和血管再阻塞等長期併發症。此外，人們越來越認知到生物分解性支架的好處，例如它們恢復動脈自然運動和功能的能力，也促進了市場的成長。然而，這些支架的高成本和嚴格的監管核准程序可能會在一定程度上阻礙市場成長。儘管面臨這些挑戰，生物分解性支架市場仍具有巨大的成長潛力，並為現有參與者和新參與企業提供了許多機會。市場競爭激烈，主要參與者都致力於研發活動，以推出創新產品並獲得競爭優勢。由於生物可分解支架在醫療保健領域的日益普及以及人們對其相對於傳統支架的優勢的認知，生物分解性支架市場的未來看起來充滿希望。

市場動態：

全球可生物分解性支架市場的主要促進因素是人們對微創治療的日益偏好、全球易患心臟病的老年人口的增加以及冠狀動脈疾病和周邊動脈疾病盛行率的增加。此外，有利的償付政策和監管部門的核准推動生物分解性支架的採用。然而，與傳統金屬支架相比，生物分解性支架的成本較高以及缺乏長期性能資料是對市場成長產生負面影響的主要因素。

本研究的主要特點

  • 本報告詳細分析了全球生物分解性支架市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
  • 強調了各個細分市場的潛在收益成長機會，並為該市場說明了一系列有吸引力的投資提案。
  • 提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
  • 根據公司亮點、產品系列、主要亮點、性能和策略等參數，介紹了全球生物分解性支架市場的主要企業。
  • 本研究涵蓋的主要企業包括 Boston Scientific Corporation、Abbott、Kyoto Medical Planning Co., Ltd.、QualiMed、Elixir Medical Corporation、ENDOCOR GmbH、BIOTRONIK SE &Co.KG、Amaranth Medical, Inc. 和 Arterial Remodeling Technologies SA。
  • 本報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
  • 全球生物分解性支架市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
  • 透過用於分析全球生物分解性支架市場的各種策略矩陣，將促進相關人員的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章 市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
  • 微創手術的採用率增加
    • 抑制因素
  • 可生物分解性支架高成本
    • 機會
  • 技術進步
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第4章 全球生物分解性支架市場－冠狀病毒（COVID-19）大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第5章 全球生物分解性支架市場，依產品類型，2018-2030

  • 冠狀動脈支架
  • 外周支架

第6章 全球生物分解性支架市場，依材料類型，2018-2030

  • 聚合物支架
  • 金屬支架

第7章 全球生物分解性支架市場，依最終使用者分類，2018-2030年

  • 醫院
  • 專科診所
  • 門診手術中心

第8章 2018-2030年全球生物分解性支架市場，依地區

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 南非
  • 中部非洲
  • 北非

第9章 競爭形勢

  • Boston Scientific Corporation
  • Abbott
  • Kyoto Medical Planning Co., Ltd.
  • QualiMed
  • Elixir Medical Corporation
  • ENDOCOR GmbH
  • BIOTRONIK SE & Co. KG
  • Amaranth Medical, Inc.
  • Arterial Remodeling Technologies SA

第10章

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI1917

The global biodegradable stents size is estimated to be at US$ 388.9 Mn in 2023 and is expected to reach US$ 634.7 Mn by 2030, growing at a compound annual growth rate (CAGR) of 7.2% from 2023 to 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023/2024: US$ 388.9 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR: 7.20% 2030/2031 Value Projection: US$ 634.7 Mn
Figure 1. Global Biodegradable Stents Market Share (%), by Region, 2023
Biodegradable Stents Market - IMG1

The biodegradable stents market is rapidly evolving within the broader medical devices industry. Biodegradable stents, also known as bioresorbable or bioabsorbable stents, are used in the treatment of coronary artery diseases or peripheral artery diseases. These stents are designed to open up blocked arteries and gradually dissolve in the body over a period of time, eliminating the need for a permanent metallic implant and reducing the risk of complications associated with traditional stents. The global biodegradable stents market is driven by several factors including the rising prevalence of cardiovascular diseases, advancements in technology, and the growing preference for minimally invasive procedures. The market is also influenced by the increasing demand for better and safer alternatives to traditional stents, which can cause long-term complications such as thrombosis and restenosis. Furthermore, growing awareness about the benefits of biodegradable stents, such as their ability to restore the natural movement and function of the artery, is also contributing to the growth of the market. However, the high cost of these stents and the stringent regulatory approval process may hinder the market growth to some extent. Despite these challenges, the biodegradable stents market holds immense potential for growth, with numerous opportunities for existing players and new entrants. The market is characterized by intense competition, with key players focusing on research and development activities to introduce innovative products and gain a competitive edge. The future of the biodegradable stents market looks promising, with increasing adoption in the healthcare sector and growing recognition of their benefits over traditional stents.

Market Dynamics:

The global biodegradable stents market is primarily driven by the growing preference for minimally invasive procedures, rising geriatric population worldwide prone to cardiac ailments, and increasing incidence of coronary and peripheral artery diseases. Additionally, favorable reimbursement policies and regulatory approvals are promoting the adoption of biodegradable stents. However, the high cost of biodegradable stents compared to conventional metallic stents and lack of long-term performance data are the major factors negatively impacting the market growth.

Key Features of the Study:

  • This report provides an in-depth analysis of the global biodegradable stents market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global biodegradable stents market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Boston Scientific Corporation, Abbott, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc., Arterial Remodeling Technologies SA.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global biodegradable stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biodegradable stents market

Detailed Segmentation:

  • Global Biodegradable Stents Market Segmentation, By Product Type:
    • Coronary Stents
    • Peripheral Stents
  • Global Biodegradable Stents Market Segmentation, By Material Type:
    • Polymer-based Stents
    • Metallic Stents
  • Global Biodegradable Stents Market Segmentation, By End User:
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
  • Global Biodegradable Stents Market Segmentation, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profile:
    • Boston Scientific Corporation
    • Abbott
    • Kyoto Medical Planning Co., Ltd.
    • QualiMed
    • Elixir Medical Corporation
    • ENDOCOR GmbH
    • BIOTRONIK SE & Co. KG
    • Amaranth Medical, Inc.
    • Arterial Remodeling Technologies SA.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Biodegradable Stents, By Product Type
    • Market Biodegradable Stents, By Material Type
    • Market Biodegradable Stents, By End User
    • Market Biodegradable Stents, By Geography/Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Growing adoption of minimally invasive procedures
    • Restraints
  • High cost of biodegradable stents
    • Opportunities
  • Technological advancements
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Biodegradable Stents Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Biodegradable Stents Market, By Product Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Coronary Stents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Peripheral Stents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. Global Biodegradable Stents Market, By Material Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Polymer-based Stents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Metallic Stents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Global Biodegradable Stents Market, By End User, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

8. Global Biodegradable Stents Market, By Region, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2019 - 2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

9. Competitive Landscape

  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Kyoto Medical Planning Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • QualiMed
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Elixir Medical Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • ENDOCOR GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BIOTRONIK SE & Co. KG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Amaranth Medical, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Arterial Remodeling Technologies SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us